|
|
DSpace at RU >
Browsing by Author Antonini, N.
Showing results 1 to 6 of 6
| Full Text | Issue Date | Title | Author(s) | | 2009 | Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. | Jones, H.A.; Antonini, N.; Hart, A.A.; Peterse, J.L.; Horiot, J.C., et al |
| 2009 | The influence of the use of CT-planning on the irradiated boost volume in breast conserving treatment. | Uwini, S. Al; Antonini, N.; Poortmans, P.M.; Boersma, L.; Hurkmans, C., et al |
| 2008 | Current questions in the treatment of advanced colorectal cancer: the CAIRO studies of the Dutch Colorectal Cancer Group. | Simkens, L.; Tol, J.; Koopman, M.; Mol, L.; Antonini, N., et al |
| 2007 | Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. | Koopman, M.; Antonini, N.; Douma, J.; Wals, J.; Honkoop, A.H., et al |
| 2007 | Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. | Antonini, N.; Jones, H.; Horiot, J.C.; Poortmans, P.; Struikmans, H., et al |
| 2006 | Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study. | Koopman, M.; Antonini, N.; Douma, J.; Wals, J.; Honkoop, A.H., et al |
Showing results 1 to 6 of 6
|